End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.92 CNY | +0.31% | +10.83% | -2.27% |
Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
Apr. 23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
Sales 2024 * | 3.99B 551M | Sales 2025 * | 4.75B 656M | Capitalization | 34.84B 4.81B |
---|---|---|---|---|---|
Net income 2024 * | 662M 91.44M | Net income 2025 * | 815M 113M | EV / Sales 2024 * | 8.6 x |
Net cash position 2024 * | 528M 72.93M | Net cash position 2025 * | 1.53B 211M | EV / Sales 2025 * | 7.02 x |
P/E ratio 2024 * |
53.6
x | P/E ratio 2025 * |
43.7
x | Employees | 3,517 |
Yield 2024 * |
0.66% | Yield 2025 * |
1.33% | Free-Float | 38.31% |
1 day | +0.31% | ||
1 week | +10.83% | ||
Current month | +9.65% | ||
1 month | +9.65% | ||
3 months | +15.11% | ||
6 months | +4.66% | ||
Current year | -2.27% |
Managers | Title | Age | Since |
---|---|---|---|
Jie Yan
CEO | Chief Executive Officer | 51 | 05-12-31 |
Ai Zhen Li
CHM | Chairman | 54 | 04-02-29 |
Yun Kong
DFI | Director of Finance/CFO | 51 | 21-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Hai Ye
BRD | Director/Board Member | 80 | 98-11-02 |
Sing Ye
CHM | Chairman | 49 | 04-06-30 |
Jian Feng Yang
BRD | Director/Board Member | 48 | 05-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.63% | 2 M€ | -12.95% | - | |
0.46% | 2 M€ | -14.14% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 31.92 | +0.31% | 5,087,003 |
24-04-29 | 31.82 | +1.79% | 3,918,100 |
24-04-26 | 31.26 | +1.13% | 4,966,779 |
24-04-25 | 30.91 | +3.14% | 5,639,419 |
24-04-24 | 29.97 | -1.90% | 5,871,349 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.27% | 4.81B | |
+20.61% | 43.18B | |
+20.67% | 22.59B | |
+14.56% | 14.56B | |
+13.94% | 13.54B | |
+43.35% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B |
- Stock Market
- Equities
- 002294 Stock